← Open Payments lookup

DEOMEL SORIANO: Open Payments

NPI 1164641650 · EL CAJON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$590 in 22 payments from 9 companies in 2025. Trend: 2023 $444 · 2024 $1,096 · 2025 $590

Food & beverage: $590
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.5$251
Alkermes, Inc.8$147
Teva Pharmaceuticals USA, Inc.2$40
E.R. Squibb & Sons, L.L.C.1$40
Neurocrine BioSciences, Inc.2$39
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$28
Janssen Pharmaceuticals, Inc1$26
Axsome Therapeutics, Inc.1$14
Neuronetics, Inc.1$6

Products named: FANAPT, ARISTADA, COBENFY, INGREZZA, CAPLYTA, SPRAVATO, UZEDY, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.